Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Self-reported mammography use following BRCA1/2 genetic testing may be overestimated.

Larouche G, Bouchard K, Chiquette J, Desbiens C, Simard J, Dorval M.

Fam Cancer. 2012 Mar;11(1):27-32. doi: 10.1007/s10689-011-9490-6.

PMID:
22080962
2.

Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?

Larouche G, Chiquette J, Pelletier S, Simard J, Dorval M.

Fam Cancer. 2017 Jan;16(1):35-40. doi: 10.1007/s10689-016-9920-6.

PMID:
27554086
3.

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.

Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Tilanus-Linthorst MM, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, de Koning HJ, Van den Heuvel ER, de Bock GH.

J Clin Oncol. 2015 Feb 1;33(4):349-56. doi: 10.1200/JCO.2014.56.6232. Epub 2014 Dec 22.

PMID:
25534390
4.

Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.

Giannakeas V, Lubinski J, Gronwald J, Moller P, Armel S, Lynch HT, Foulkes WD, Kim-Sing C, Singer C, Neuhausen SL, Friedman E, Tung N, Senter L, Sun P, Narod SA.

Breast Cancer Res Treat. 2014 Aug;147(1):113-8. doi: 10.1007/s10549-014-3063-y. Epub 2014 Aug 1.

PMID:
25082516
5.

Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Rosen B, Kim-Sing C, Isaacs C, Domchek S, Sun P; Hereditary Breast Cancer Clinical Study Group.

Lancet Oncol. 2006 May;7(5):402-6. Erratum in: Lancet Oncol. 2006 Jun;7(6):453. Domcheck, Susan [corrected to Domchek, Susan].

PMID:
16648044
6.

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.

Fakkert IE, Jansen L, Meijer K, Kok T, Oosterwijk JC, Mourits MJ, de Bock GH.

Breast Cancer Res Treat. 2011 Aug;129(1):157-64. doi: 10.1007/s10549-011-1423-4. Epub 2011 Mar 4.

PMID:
21373873
7.

Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers.

Pijpe A, Mulder RL, Manders P; HEBON, van Leeuwen FE, Rookus MA.

J Clin Epidemiol. 2011 Dec;64(12):1434-43. doi: 10.1016/j.jclinepi.2011.04.005. Epub 2011 Jul 20.

PMID:
21764559
8.

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E.

Am J Med Genet A. 2003 Apr 30;118A(3):201-9.

PMID:
12673648
9.

Screening adherence in BRCA1/2 families is associated with primary physicians' behavior.

Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT.

Am J Med Genet A. 2004 Feb 15;125A(1):5-11.

PMID:
14755459
10.

Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.

McCarthy AM, Bristol M, Fredricks T, Wilkins L, Roelfsema I, Liao K, Shea JA, Groeneveld P, Domchek SM, Armstrong K.

Cancer. 2013 Oct 15;119(20):3596-603. doi: 10.1002/cncr.28268. Epub 2013 Jul 16.

11.

Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.

Huo Z, Giger ML, Olopade OI, Wolverton DE, Weber BL, Metz CE, Zhong W, Cummings SA.

Radiology. 2002 Nov;225(2):519-26.

PMID:
12409590
12.

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.

Peshkin BN, Schwartz MD, Isaacs C, Hughes C, Main D, Lerman C.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1115-8.

13.

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec.

Dorval M, Noguès C, Berthet P, Chiquette J, Gauthier-Villars M, Lasset C, Picard C, Plante M; INHERIT BRCAs; GENEPSO Cohort, Simard J, Julian-Reynier C.

Eur J Hum Genet. 2011 May;19(5):494-9. doi: 10.1038/ejhg.2010.227. Epub 2011 Jan 19.

14.

Measuring adherence to mammography screening recommendations among low-income women.

Armstrong K, Long JA, Shea JA.

Prev Med. 2004 Jun;38(6):754-60.

PMID:
15193895
15.

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.

Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):445-55. doi: 10.1158/1055-9965.EPI-11-0991. Epub 2012 Feb 10.

16.

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.

Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Potterton J, Thompson D, Turnbull LW, Walker LG, Warren R, Leach MO; UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group.

Br J Cancer. 2006 Oct 9;95(7):801-10.

17.

BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.

McInerney-Leo A, Hadley D, Kase RG, Giambarresi TR, Struewing JP, Biesecker BB.

Am J Med Genet A. 2006 Oct 15;140(20):2198-206.

PMID:
16969872
18.

Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.

Hall MJ, Reid JE, Wenstrup RJ.

Cancer Prev Res (Phila). 2010 Dec;3(12):1579-85. doi: 10.1158/1940-6207.CAPR-09-0218.

19.

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.

Saadatmand S, Vos JR, Hooning MJ, Oosterwijk JC, Koppert LB, de Bock GH, Ausems MG, van Asperen CJ, Aalfs CM, Gómez Garcia EB, Meijers-Heijboer H, Hoogerbrugge N, Piek M, Seynaeve C, Verhoef C, Rookus M, Tilanus-Linthorst MM; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON).

Int J Cancer. 2014 Dec 15;135(12):2940-9. doi: 10.1002/ijc.28941. Epub 2014 May 20.

20.

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges VF, Larsen B, Garber JE, Partridge AH.

JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.

Supplemental Content

Support Center